
No data
No data
No data
| CAS Number | 127-07-1 |
| Catalog Number | AG000WIJ(AGN-PC-009Q8Z) |
| Chemical Name | Urea, N-hydroxy- |
| IUPAC Name | hydroxyurea |
| InChI | InChI=1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4) |
| InChI Key | VSNHCAURESNICA-UHFFFAOYSA-N |
| MDL Number | MFCD00007943 |
| Molecular Formula | CH4N2O2 |
| Molecular Weight | 76.0547 |
| RTECS Number | YT4900000 |
| SMILES | O=C(N)NO |
| UN Number | 2811 |
| UNII | X6Q56QN5QC |
| Synonyms | Hydrea,
Hydroxycarbamid,
Hydroxyurea,
Oncocarbide,
hydroxyurea,
Hydroxycarbamide,
127-07-1,
N-Hydroxyurea,
1-HYDROXYUREA,
Hydrea,
Oxyurea,
Carbamoyl oxime,
Biosupressin,
Hydroxycarbamine,
Onco-carbide,
Carbamohydroxamic acid,
Carbamohydroximic acid,
Hydura,
Litalir,
Carbamyl hydroxamate,
Hydurea,
N-Carbamoylhydroxylamine,
Urea, hydroxy-,
Droxia,
Hidrix,
Hydroxicarbamidum,
Siklos,
Hydroxylurea,
Hydreia,
Litaler,
Idrossicarbamide [DCIT],
Hidroxicarbamida,
Hydroxyharnstoff,
Hydroxycarbamidum,
Carbamohydroxyamic acid,
N-Hydroxymocovina,
Hydroxylamine, N-carbamoyl-,
Hydroxyharnstoff [German],
N-Hydroxymocovina [Czech],
SQ 1089,
NCI-C04831,
Hydroxylamine, N-(aminocarbonyl)-,
Carrbamoyl Oxime,
SK 22591,
Hydroxycarbamidum [INN-Latin],
Hidroxicarbamida [INN-Spanish],
urea, N-hydroxy-,
HU,
CCRIS 958,
HYDROXY-UREA,
NSC 32065,
N-HYDROXY UREA,
UNII-X6Q56QN5QC,
NSC32065,
MFCD00007943,
N-(Aminocarbonyl) Hydroxyamine,
AI3-51139,
HSDB 6887,
Hydroxyurea (Cytodrox),
EINECS 204-821-7,
CHEMBL467,
SQ-1089,
BRN 1741548,
X6Q56QN5QC,
CHEBI:44423,
VSNHCAURESNICA-UHFFFAOYSA-N,
Hydroxyurea, 98%,
Hydroxy Urea-15N,
NCGC00015520-03,
Hydroxycarbamid,
Oncocarbide,
Idrossicarbamide,
DSSTox_CID_5438,
DSSTox_RID_77787,
DSSTox_GSID_25438,
NHY,
Hydroxyurea (D4),
Mylocel,
carbamide oxide,
Hydroxyurea [USAN:BAN],
CAS-127-07-1,
SMR000059149,
Hydroxyurea (USP),
Droxia (TM),
Droxia (TN),
Hydrea (TM),
hydroxyaminomethanamide,
SR-01000075919,
DRG-0253,
HYDREA (TN),
Hydroxyurea [USAN:USP],
Hydroxycarbamide (JAN/INN),
Cytodrox,
hydroxyl urea,
hydroxy urea,
1-oxidanylurea,
S-phase/G-1 interface inhibitor,
aminohydroxamic acid,
carbamic acid oxime,
Carbomohydroxamic acid,
Hydroxyurea(Cytodrox),
Spectrum_000909,
Hydroxycarbamide [INN],
WLN: ZVMQ,
AC1Q4ZXK,
Hydrea (Bristol Meyers),
Spectrum2_000064,
Spectrum3_000462,
Spectrum4_000012,
Spectrum5_000836,
Lopac-H-8627,
MolMap_000029,
H 8627,
NCIMech_000139,
AC1L1GF8,
Hydroxyurea, 98%, powder,
ACMC-1C22W,
Lopac0_000596,
BSPBio_002164,
KBioGR_000383,
KBioSS_001389,
4-03-00-00170 (Beilstein Handbook Reference),
hydroxycarbamide (hydroxyurea),
KSC490O3R,
MLS001332381,
MLS001332382,
MLS002153389,
DivK1c_000556,
N-(Aminocarbonyl)hydroxylamine,
SPECTRUM1500344,
SPBio_000247,
GTPL6822,
DTXSID6025438,
tetratogen: inhibits ribonucleoside diphosphate reductase,
CTK3J0738,
HMS501L18,
KBio1_000556,
KBio2_001389,
KBio2_003957,
KBio2_006525,
KBio3_001384,
NINDS_000556,
Bio1_000451,
Bio1_000940,
Bio1_001429,
HMS1920F09,
HMS2091L17,
HMS2234I03,
HMS3261H14,
HMS3373G18,
HMS3655K20,
NCI C04831,
Pharmakon1600-01500344,
ACT02611,
ALBB-028465,
EBD12517,
HY-B0313,
ZINC8034120,
Tox21_110168,
Tox21_300319,
Tox21_500596,
ANW-18958,
BBL009928,
BDBM50017811,
CCG-35236,
LS-709,
NSC-32065,
NSC757072,
s1896,
STL145898,
AKOS005716276,
AKOS006222547,
Tox21_110168_1,
ZINC100019199,
AN-6974,
CS-2353,
DB01005,
LP00596,
MCULE-9465284053,
NSC-757072,
RP18352,
RTR-003905,
IDI1_000556,
KS-0000020X,
TRA-0204880,
NCGC00015520-01,
NCGC00015520-02,
NCGC00015520-04,
NCGC00015520-05,
NCGC00015520-06,
NCGC00015520-07,
NCGC00015520-08,
NCGC00015520-09,
NCGC00015520-10,
NCGC00015520-11,
NCGC00093974-01,
NCGC00093974-02,
NCGC00093974-03,
NCGC00093974-04,
NCGC00093974-05,
NCGC00254007-01,
NCGC00261281-01,
AC-22674,
AK128930,
NCI60_002773,
SC-17803,
SBI-0050578.P004,
AB0013265,
AB1009531,
ST2415349,
TL8000673,
TR-003905,
EU-0100596,
FT-0083575,
FT-0627160,
SW218071-2,
C07044,
D00341,
H20210,
Hydroxyurea, Vetec(TM) reagent grade, >=98%,
AB00052018-09,
AB00052018-10,
AB00052018_11,
AB00052018_12,
127H071,
A805636,
I05-0250,
J-504798,
SR-01000075919-1,
SR-01000075919-3,
SR-01000075919-8,
E0723DBA-5AF3-49D1-B5F6-59420AB87AC9,
F8880-0905,
Z1522566612,
Hydroxycarbamide, European Pharmacopoeia (EP) Reference Standard,
Hydroxyurea, United States Pharmacopeia (USP) Reference Standard,
8029-68-3,
oxyrea,
Ureaphil,
Hydrixycarbamide,
Sterile Urea,
Hydroxyurea(d4),
HYDROXYUREA 5G,
D07CWD,
CH4N2O2,
Hydroxyurea, 98% - 1G 1g,
CID3657,
C-H4-N2-O2,
Hydrea, Biosupressin, Cytodrox, Hydroxyurea,
B2102,
H0310,
A10459,
D006918,
1-(6-aminopurin-9-yl)propan-2-yloxymethylphosphonic acid,
214331-53-0,
|
| Complexity | 42.9 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 76.027g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 5 |
| Hydrogen Bond Acceptor Count | 2 |
| Hydrogen Bond Donor Count | 3 |
| Isotope Atom Count | 0 |
| Molecular Weight | 76.055g/mol |
| Monoisotopic Mass | 76.027g/mol |
| Rotatable Bond Count | 0 |
| Topological Polar Surface Area | 75.4A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -1.8 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335-H350-H360 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code | \N |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

